Treatment Discontinuation of Long-Acting Injectables or Oral Atypical Antipsychotics Among Medicaid Recipients With Schizophrenia
Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2019.1615927
Full Text
Open PDFAbstract
Available in full text
Categories
Date
May 23, 2019
Authors
Publisher
Informa UK Limited